We’re the Abbotsford-Mission Family Practice Residency Team based out of Abbotsford and Mission, British Columbia, Canada. We’re passionate about medicine, your educational journey, and delivering the best care to our community. We know you have several choices ahead and we’re here to help you in making the right decision for your future. Learn more about our program here.
“Ware wanted to share the illustration to say, ‘Look, we can do better — this is what it looks like to make change in the medical industrial complex.’
‘This young medical illustrator who’s training to be a neurosurgeon is doing just that. He’s interrupting the process of white supremacy and instead saying, in fact, I want to imagine Black babies being born in this world, so I’m going to draw them … It really shows the importance of representation and supporting those medical illustrators who can actually tell our stories as part of their medical work.'”
More on llustration of Black fetus has Canadian parents, educators calling for diversity in medical resources via CBC.
“The Sandy Hook, Dayton, and El Paso mass killings have all involved children being victims of violence or losing their parents. It’s not difficult to infer the subsequent lack of gun control essentially means that the public have accepted the murder and suffering of children. This is more than social media rhetoric; children continue to be separated from their parents and/or family members at our borders, and the ongoing practice of separating children from relatives or siblings, while familial ties are validated can take weeks to months. This is not a north American phenomenon as the ongoing plight of Syrian and Libyan refugees demonstrates. As practicing pediatricians and neonatologists, we are enraged that our countries and world, accepts these events happening to children. Why is a principle of zero tolerance not applied to these tragedies, as it is in Sweden to road deaths? (https://www.york.ac.uk/news-and-events/news/2006/zero-tolerance/).
Thus, the question thus arises about the value of children in society. Two decades ago, the Institute of Medicine published a book on the impact of the environment on children, Children’s Health, the Nation’s Wealth. In it is the following sentence on how our societies value our children: ‘The social transformation of childhood in modern societies reflects a retreat from the view that parents have full and unlimited jurisdiction over their children to one, in which the welfare of children is increasingly understood as a shared social responsibility, which requires investments in education, health care, and other institutions.’ Those other institutions may be seen to be institutions engaged in research that assesses and improves child health, both for the child and for the adult the child will become.
From this sentence quoted above, it seems as though the value of our children to society has steadily risen over the past few centuries, since the rights of the child were enshrined in the United Nations convention.
But it seems now that we are in a downward spiral. That the value of children depends on whose child. That the value of children depends on their ethnicity, the wealth of their parents, their genetic makeup, and their socioeconomic level. For example, the infant mortality rate in the US is higher among Black non-Hispanic infants, Native American infants, and Hispanic infants than white non-Hispanic infants (https://www.childstats.gov/americaschildren/infant_mortality.asp).”
This talk is part of a limited series co-presented by SBME, BMI&AI, and BC Translational DPI.
Talk: “Artificial Intelligence and digital pathology: dealing with the annotation bottleneck”
The introduction of scanners that are capable of digitizing microscopic slides at high magnification has led to an explosion of interest in computational pathology in general and deep learning applied to whole slide images (WSIs) in particular. In my lab at Sunnybrook, we are developing AI models that can detect cancer, automatically segment regions of interest, and learn predictive and prognostic models that can be used to guide treatment decisions. In this talk I will outline some of the unique challenges of working with these extremely large WSIs and discuss some of the approaches that we have developed to overcome the problems of sparse annotations and weak, noisy labels, including self-supervision and multiple instance learning. I will also outline some of the challenges in deploying AI algorithms to the clinic.
“According to the World Health Organization and cardiology societies, myocarditis is defined as an inflammatory disorder of the heart muscle that is characterized by lymphocytic and monocytic infiltrates within the myocardium, myocyte degeneration, and nonischemic necrosis (the so-called Dallas criteria). … It follows that for a truly definitive diagnosis of myocarditis occurring after vaccination, endomyocardial biopsy would need to be performed and viral myocarditis (including from Covid-19 infection) would need to be ruled out to exclude a chance occurrence of myocarditis temporally associated with the vaccine. … Most of the reported cases that occurred after vaccination had an uneventful course. The take-home messages from the two studies may be that clinically suspected myocarditis is temporally associated with the BNT162b2 mRNA vaccine but is rare, is more common in young male patients, and (with a few exceptions) is self-limiting. As acknowledged by the authors, temporal association does not imply causation, and the risk of vaccinal myocarditis is very low. The results of these two studies are valuable for doctors, patients, and the public to reduce the fear of myocarditis as a reason for excluding young people from vaccination, especially since myocarditis has also been temporally associated with Covid-19. Meanwhile, active surveillance for myocarditis should continue, and endomyocardial biopsy could be performed in severe cases to affirm the diagnosis and possibly to guide therapy, such as the use of antiviral drugs or immunosuppressive and immunomodulatory agents.”
More on Receipt of mRNA Vaccine against Covid-19 and Myocarditis via NEJM.
“’Conversion therapy’ is an umbrella term describing a poorly defined set of psychological, behavioural, physical and faith-based interventions that work to suppress same-sex attraction, or to deter patients from expressing gender identities discordant with sex assigned at birth. More than 50 health professional organizations — including the Canadian Psychiatric Association and American Medical Association — have issued consensus statements denouncing conversion therapy, owing to substantial empirical evidence that these practices are ineffective and associated with poor health outcomes, notably including suicide ideation and attempts. Despite these denouncements, conversion therapy continues to occur in Canada, in both licensed and unlicensed practice settings, affecting as many as 10% of Two-Spirit, lesbian, gay, bisexual, transgender and queer (2SLGBTQ+) people. The recent passage by the federal Parliament of Bill C-4, banning conversion therapy, creates a new opportunity for synergy between medicine and the law, protecting the rights and health of 2SLGBTQ+ people in Canada. … Canada’s medical regulators should act to augment any federal legislation by making it clear that they will take prompt disciplinary action against members who cause harm through engaging in or supporting conversion therapy interventions. Although several provinces and territories (e.g., Ontario, Nova Scotia and Yukon) have passed legislation prohibiting the use of public funds for conversion therapy, it is unclear how these laws are currently enforced, and mutually reinforcing strategies to deter conversion therapy practices — including legislation and regulatory action — are likely required, given the insidious and covert forms these practices often take. Canadian citizens have the right to access 2SLGBTQ+-affirming medical care. Therefore, individual physicians who are unfamiliar or uncomfortable with providing gender-affirming medicine have a responsibility to refer their patients to doctors who can provide these services.”
More on Ridding Canadian medicine of conversion therapy via CMAJ.
“Fungi represent one of the most diverse and abundant eukaryotes on earth. The interplay between mold exposure and the host immune system is still not fully elucidated. Literature research focusing on up-to-date publications is providing a heterogenous picture of evidence and opinions regarding the role of mold and mycotoxins in the development of immune diseases. While the induction of allergic immune responses by molds is generally acknowledged, other direct health effects like the toxic mold syndrome are controversially discussed. However, recent observations indicate a particular importance of mold/mycotoxin exposure in individuals with pre-existing dysregulation of the immune system, due to exacerbation of underlying pathophysiology including allergic and non-allergic chronic inflammatory diseases, autoimmune disorders, and even human immunodeficiency virus (HIV) disease progression. In this review, we focus on the impact of mycotoxins regarding their impact on disease progression in pre-existing immune dysregulation. This is complemented by experimental in vivo and in vitro findings to present cellular and molecular modes of action. Furthermore, we discuss hypothetical mechanisms of action, where evidence is missing since much remains to be discovered.”
“The typical impact on morbidity and mortality for those with type 2 diabetes is rather grim and in excess of many cancers. The average 10-year survival rates for breast cancer and non-Hodgkin lymphoma are 84% and 55%, respectively; the average 10-year lifespan for type 2 diabetes is 50%. While the goal for most patients with cancer is remission, the patient with type 2 diabetes is taught that they need to live with this incurable disease. This need not be the case.
Increasing evidence points to the ability of patients to not only halt the onset of type 2 diabetes, but also to enter remission after a type 2 diabetes diagnosis. Bariatric surgery (RYGB, BPD) has been shown to result in durable remission in the majority of patients with type 2 diabetes, and research has demonstrated that counseling patients to engage in modest caloric reduction using portion control and limited use of meal replacements resulted in roughly 10% of patients experiencing remission after 2 years.
The Diabetes Remission Clinical Trial (DiRECT) in particular provides compelling evidence for the efficacy of structured, diet-induced weight loss on type 2 diabetes remission outcomes. The randomized controlled trial’s intervention consisted of withdrawal of antidiabetic/antihypertensive drugs, total diet replacement for 12 to 20 weeks, stepped food reintroduction (2 to 8 weeks), and then structured support for weight-loss maintenance. At 24 months, 36% of intervention group participants had remission of diabetes, lower weight (average 8 kg), lower blood pressure, a 50% reduction in cardiovascular disease risk, lower health care costs, and better quality of life. Post-hoc analysis of patients experiencing remission found a return to normal pancreas volume, morphology, and beta cell capacity. Importantly, the trial was conducted entirely in primary care practices, assisted by nurses and dietitians.”
Read more on Type 2 diabetes: Turning management into remission via BCMJ. Also view Roundup: 25 Artists Sweetening Their Works With Diabetes Illustrations via DesignMantic.
Join our highly experienced and knowledgeable panelists as they answer your questions and share best practices in managing virtual musculoskeletal examinations (specifically, wrist/hand and shoulder) in the context of the COVID-19 pandemic.
Feb 10 (Thu) | 1830–2000 PST Target Audience: Physicians and other health care providers. Meet our panel:
Dr. Fay Leung, Orthopedic Surgeon, Clinical Associate Professor, UBC Department of Orthopaedics
Dr. Rod French, Plastic Surgeon, Clinical Assistant Professor, UBC Division of Plastic Surgery
“The National University Health System in Singapore has started a research and development programme to explore the use of mixed reality technology in clinical care.
In a press statement, the healthcare group said a team of neurosurgeons from the National University Hospital has studied the potential of holographic technology to locate brain tumours during surgeries.
WHAT IT DOES
In a proof of concept demonstration, a holographic visor was used to create a 3D hologram of a patient’s brain scan that was projected into space and superimposed onto a patient’s head during surgery.
The hologram was generated using a 3D medical software called Virtual Surgery Intelligence by German medical MR platform developer apoQlar.
The MR technology enables surgeons to identify tumours ‘quickly and precisely’ and know their exact location and which angle to make an incision. Surgeons can also view the holographic image from different angles, as well as interact with and control it by gesture and speech recognition.”
Read more on NUHS demonstrates use of holographic tech in brain surgery: The healthcare group has started exploring the use of mixed-reality tech in clinical care via HIMSS.